ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for ...
Not so, if you use a pair of specialised ultrasonic transducer arrays to move the air instead! (Video, embedded below) Three banks of thrusters provide a 180 degree steerable net force Details are ...
Novocure (NVCR) announced that the FDA approved its new head flexible electrode, or HFE, transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme ...
Not so, if you use a pair of specialised ultrasonic transducer arrays to move the air instead! (Video, embedded below) Three banks of thrusters provide a 180 degree steerable net force Details are ...